Sandeep Laumas, CEO, Executive Chairman at INNOVATE BIOPHARMACEUTICALS, INC. (INNT), bought 5,000 shares at $1.38 ($7K) on 2019-05-22, disclosed to the SEC on 2019-05-23.
Open-market purchase of $7k INNT by CEO, Executive Chairman. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Clearly above the average filing.
| Filing → |
| INNT | BUY | 2019-06-17 | $1K | — | Filing → |
| INNT | BUY | 2018-12-03 | $8K | — | Filing → |
| INNT | BUY | 2018-11-29 | $8K | — | Filing → |